Viewing Study NCT05317767


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-04-18 @ 3:57 PM
Study NCT ID: NCT05317767
Status: COMPLETED
Last Update Posted: 2022-04-08
First Post: 2021-10-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years.
Sponsor: St. Petersburg Research Institute of Vaccines and Sera
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module